Abstract
Inflammation is a complex process which presents several targets for drug action and a large number of chemically unrelated drugs have been used in the treatment of inflammatory diseases. There are, however, signs and symptoms which are common to inflammatory responses induced by different trauma. Furthermore, it is evident that many anti-inflammatory drugs share the same therapeutic and toxic effects. Vane (1971) has suggested that the anti-inflammatory effects and the gastrointestinal irritancy of aspirin-like drugs is due to the inhibition of prostaglandin synthesis. Evidence is now accumulating which links the inhibition of arachidonic acid metabolism to the mechanism of action of the two major groups of anti-inflammatory drugs, the corticosteroids and the non-steroid aspirin-like drugs. In this paper these theories will be reviewed and their implications for future drug development will be discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
